National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Pitavastatin is indicated for the reduction of elevated TC and LDL-C, in adult patients with primary hypercholesterolaemia, including heterozygous familial hypercholesterolaemia and combined (mixed) dyslipidaemia, when response to diet and other non-pharmacological measures are inadequate.

Rapid Review

Commenced Completed Outcome
22/12/2010 24/12/2010 Full Pharmacoeconomic Evaluation not Recommended.